International Trade committee  CETA has provided important IP enhancements that we have been leveraging very successfully. We're putting our money where our mouth is regarding attracting R and D investment to Canada and competing on the global stage for research and development investment.

International Trade committee  Certainly, our organization watches and looks closely at all international trade agreements, as they may have an impact on our business, whether it's the movement of goods or whether it's related to research and development or intellectual property. Our company was around the tab

International Trade committee  Our employment is 15,000, and indirect is up to 31,000 employees in Canada. Perhaps I could just add to it, because I think I understand where your question is going. In addition to the research and development we do, we have a major manufacturing plant in Guelph that manufactu

International Trade committee  Thank you. Medicine pricing is a global decision by our organizations. We bring innovative medicines to 160 countries around the world, so we need to consider global issues when it comes to medicine pricing. Here in Canada the pricing of medicines is significantly controlled, a

International Trade committee  It certainly is part of life. It's part of the dialogue between the generic industry and the innovator industry. Generally, there are resolutions that are reached over time. It's quite clear that the generic industry brings tremendous value to the health care system. They help l

International Trade committee  Certainly, the agreements that have helped to level the playing field on intellectual property on a global perspective allow Canada to compete for global research and development dollars. Our company, J&J, invests $8 billion globally. On the heels of CETA, we have been succes

International Trade committee  Thank you very much for the question. First of all, Canada operates in a very highly controlled price environment for pharmaceuticals. There are multiple layers of bureaucracy between an innovation and that medicine's getting to a patient through a payer. Included in those layer

International Trade committee  I think the decisions around life sciences and research and development investment are multifactorial. They do not involve just intellectual property; they involve a number of other components. Perhaps the biggest and most important is the quality of science and scientists. Canad

International Trade committee  Yes. Thank you for the question. First of all, I think it's important to recognize that any changes in intellectual property are ensconced in CETA, the agreement between Canada and Europe. The TPP mirrors CETA. If and when CETA is ratified, that meets the requirements for the Tr

International Trade committee  The fourth claim made by TPP critics is that the Canadian system already provides sufficient intellectual property supports for life sciences competition and innovation. Mr. Chair, in the life sciences context, patents and data protection act as incentives for biopharmaceutical